CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 64 filers reported holding CHEMOCENTRYX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,997,000 | -55.8% | 116,113 | -78.8% | 0.01% | -12.5% |
| Q2 2022 | $13,558,000 | +1182.7% | 547,112 | +1199.2% | 0.01% | +700.0% |
| Q1 2022 | $1,057,000 | -90.4% | 42,112 | -86.1% | 0.00% | -50.0% |
| Q4 2021 | $11,012,000 | +78.9% | 302,432 | -16.0% | 0.00% | -33.3% |
| Q3 2021 | $6,154,000 | +19.4% | 359,849 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $5,153,000 | +5.4% | 384,888 | +303.2% | 0.00% | 0.0% |
| Q1 2021 | $4,891,000 | +360.1% | 95,453 | +455.8% | 0.00% | +200.0% |
| Q4 2020 | $1,063,000 | -76.8% | 17,173 | -79.5% | 0.00% | -66.7% |
| Q3 2020 | $4,583,000 | -39.9% | 83,627 | -36.9% | 0.00% | -40.0% |
| Q2 2020 | $7,623,000 | +67.0% | 132,475 | +16.6% | 0.01% | +66.7% |
| Q1 2020 | $4,566,000 | +169.7% | 113,601 | +165.3% | 0.00% | +200.0% |
| Q4 2019 | $1,693,000 | +308.9% | 42,818 | -30.0% | 0.00% | – |
| Q3 2019 | $414,000 | -46.0% | 61,183 | -25.8% | 0.00% | – |
| Q2 2019 | $767,000 | +321.4% | 82,440 | +528.6% | 0.00% | – |
| Q1 2019 | $182,000 | +188.9% | 13,114 | +123.6% | 0.00% | – |
| Q4 2018 | $63,000 | -67.5% | 5,866 | -61.7% | 0.00% | – |
| Q3 2018 | $194,000 | +73.2% | 15,304 | +80.3% | 0.00% | – |
| Q2 2018 | $112,000 | -37.1% | 8,489 | -35.0% | 0.00% | – |
| Q1 2018 | $178,000 | +584.6% | 13,066 | +193.9% | 0.00% | – |
| Q4 2017 | $26,000 | +100.0% | 4,445 | +151.8% | 0.00% | – |
| Q3 2017 | $13,000 | -60.6% | 1,765 | -50.1% | 0.00% | – |
| Q2 2017 | $33,000 | +22.2% | 3,536 | -7.8% | 0.00% | – |
| Q1 2017 | $27,000 | +80.0% | 3,835 | +91.1% | 0.00% | – |
| Q4 2016 | $15,000 | +1400.0% | 2,007 | +1015.0% | 0.00% | – |
| Q3 2016 | $1,000 | -96.4% | 180 | -97.1% | 0.00% | – |
| Q2 2016 | $28,000 | – | 6,275 | +2558.9% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 236 | -93.8% | 0.00% | – |
| Q4 2015 | $31,000 | -56.9% | 3,837 | -68.0% | 0.00% | – |
| Q3 2015 | $72,000 | +1700.0% | 11,976 | +2065.6% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 553 | -45.8% | 0.00% | – |
| Q1 2015 | $6,000 | -99.2% | 1,020 | -99.1% | 0.00% | -100.0% |
| Q4 2014 | $717,000 | +662.8% | 119,410 | +407.4% | 0.00% | – |
| Q3 2014 | $94,000 | -13.0% | 23,536 | +9.7% | 0.00% | – |
| Q2 2014 | $108,000 | -35.7% | 21,462 | -23.0% | 0.00% | – |
| Q1 2014 | $168,000 | +112.7% | 27,885 | +73.8% | 0.00% | – |
| Q4 2013 | $79,000 | +154.8% | 16,046 | +166.3% | 0.00% | – |
| Q3 2013 | $31,000 | +72.2% | 6,026 | +371.5% | 0.00% | – |
| Q2 2013 | $18,000 | – | 1,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |